Short- to Midterm Safety and Efficacy of Prostatic Artery Embolization: A Systematic Review

Cizman, Ziga; Isaacson, Ari J.; Burke, Charles T.

doi:10.1016/j.jvir.2016.04.015

Cited by 26 publications

(24 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Systemic reviews and meta-analyses provide an overview of published results to guide treatment decisions (4-7). Uflacker et al (4) (7) analyzed seven studies with improvement in IPSS, quality-of-life scores, Q max rates, PVR volumes, and PSA levels. Two hundred minor complications and one major complication were reported.…”

Section: Procedures Outcomesmentioning

confidence: 99%

Prostatic Artery Embolization for Benign Prostatic Hyperplasia: Patient Evaluation, Anatomy, and Technique for Successful Treatment

et al. 2019

View full text Add to dashboard Cite

show abstract

Section: Procedures Outcomesmentioning

confidence: 99%

Prostatic Artery Embolization for Benign Prostatic Hyperplasia: Patient Evaluation, Anatomy, and Technique for Successful Treatment

et al. 2019

View full text Add to dashboard Cite

show abstract

“…According to the Society of Interventional Radiology [ 31 ], PAE might lead to minor and major complications. Cizman et al [ 32 ] reported side effects of embolization i.e. pain, hematuria, hematospermia, urethral burning, rectal bleeding, urinary tract infection, balanitis, hematoma, diarrhoea, dissection, acute urinary retention, non-target embolization.…”

Section: Methodsmentioning

confidence: 99%

“…Non-target embolization can also be sometimes categorised as a major complications. It depends on necessity of the therapy, overnight admission, or prolonged hospitalization [ 19 , 31 , 32 ].…”

Section: Methodsmentioning

confidence: 99%

The application of prostate artery embolization in the management of intractable prostate bleeding

Stężewska

Żabicki

et al. 2020

Cent european J Urol

View full text Add to dashboard Cite

Introduction Prostate cancer is one of the most common malignancies affecting European men. Sequelae of the advanced malignancy require invasive procedures which may not be eligible especially for old, debilitated patients. The aim of this manuscript is to review the outcomes of prostate artery embolization in the management of refractory bleeding. Material and methods A PubMed database search was done for all English language articles on prostate artery embolization in prostate cancer, published between 2003 and 2019. For current review, information related to number, age of the patients, aetiology of the hematuria, bilateral or unilateral procedure, type of embolic material, technical and clinical success, complications, recurrent hematuria, hematocrit and hemoglobin levels were analyzed. Results A total of 10 original full-text comparative and non-comparative (case series) studies were reviewed. Minor complications described in the literature ranged from 10–50%. After prostate artery embolization, the recurrence of the haematuria occurred in 10–57% of the patients. Moreover, prostate artery embolization successfully treated lower urinary tract symptoms and urinary retention in prostate cancer patients. Conclusions The procedure appears safe, burdened with low risk of complications and accomplishes technical and clinical success. It is a promising option for patients with hemorrhage, but due to the scarcity of data further investigations are needed.

show abstract

“…More severe complications are related to nontarget embolization such as bladder ischemia/necrosis and gluteal ischemia. 62…”

Section: Prostatementioning

confidence: 99%

Palliative Embolization for Refractory Bleeding

Niekamp

Sheth

Kuban

et al. 2017

Semin intervent Radiol

View full text Add to dashboard Cite

Bleeding is a common and often challenging complication of malignancy. Etiologies of hemorrhage in this patient population vary, and bleeding may present as an acute, life-threatening emergency or a chronic, low-volume blood loss. For patients with advanced malignancies, interventions to manage bleeding must be balanced by the patient's life expectancy and quality of life. As such, minimally invasive procedures such as transarterial embolization are useful therapeutic options in appropriately selected patients. There is a rich history of palliative transarterial embolization for refractory bleeding in cancer patients. This technique was first applied in the 1970s and has since become an established treatment tool for malignancy-related bleeding throughout the body. While the preponderance of published data comprised case reports and small retrospective studies, the use of embolization continues to expand as experience grows and techniques are refined. In this review, we summarize the literature and provide our perspective on embolization for refractory bleeding in cancer patients.

show abstract

Short- to Midterm Safety and Efficacy of Prostatic Artery Embolization: A Systematic Review

Cited by 26 publications

References 25 publications

Prostatic Artery Embolization for Benign Prostatic Hyperplasia: Patient Evaluation, Anatomy, and Technique for Successful Treatment

Prostatic Artery Embolization for Benign Prostatic Hyperplasia: Patient Evaluation, Anatomy, and Technique for Successful Treatment

The application of prostate artery embolization in the management of intractable prostate bleeding

Palliative Embolization for Refractory Bleeding

Contact Info

Product

Resources

About